FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2094103522> ?p ?o ?g. }

• W2094103522 endingPage "88" @default.
• W2094103522 startingPage "80" @default.
• W2094103522 abstract "Karyotype is a powerful prognostic factor for complete remission (CR) and overall survival (OS) in acute myelogenous leukemia (AML). Adverse-risk karyotype AML is now treated with intensive chemotherapy followed by allogeneic hematopoietic stem cell transplantation (allo-HSCT) to overcome relapse. We attempted to stratify patients with this disease using a combination of known factors. We evaluated clinical correlates in 211 adults with AML and adverse-risk karyotypes. We divided the patients into several subgroups based on the number of chromosomal aberrations (NCAs), normal karyotype (NK) mosaicism, and monosomal karyotype (MK) status. CR rates and survival outcomes were compared among the subgroups, and the relapse rate was calculated in the allo-HSCT subgroup. The cutoff of NCA ≥5 showed the worst OS (P < .001) compared with NCA ≥3 or NCA ≥4 even after allo-HSCT. NK mosaicism significantly improved OS in both the NCA <5 (P = .024) and NCA ≥5 (P = .030) subgroups, but after allo-HSCT, it showed a favorable effect only in the NCA <5 subgroup. MK showed worse OS (P = .041), but there was no significantly worse effect after allo-HSCT compared with non-MK. Finally, we stratified patients into 4 subgroups, NCA ≥5 and NCA <5 with and without NK mosaicism. The most favorable OS and lower relapse rate after allo-HSCT were achieved by the NCA <5 with NK mosaicism subgroup, and the NCA ≥5 without NK mosaicism subgroup showed the worst prognosis in both entire group and allo-HSCT subgroup analysis. This study reveals that the combination of NCA and NK mosaicism may predict survival outcomes accurately, and suggests that novel treatment strategies for highly adverse-risk group AML should be tailored in the future." @default.
• W2094103522 created "2016-06-24" @default.
• W2094103522 creator A5019604231 @default.
• W2094103522 creator A5026190297 @default.
• W2094103522 creator A5033356298 @default.
• W2094103522 creator A5034751203 @default.
• W2094103522 creator A5036020306 @default.
• W2094103522 creator A5044372572 @default.
• W2094103522 creator A5050292329 @default.
• W2094103522 creator A5055206475 @default.
• W2094103522 creator A5059291757 @default.
• W2094103522 creator A5061707434 @default.
• W2094103522 creator A5074128691 @default.
• W2094103522 creator A5084426605 @default.
• W2094103522 creator A5086415059 @default.
• W2094103522 creator A5086500437 @default.
• W2094103522 date "2014-01-01" @default.
• W2094103522 modified "2023-10-18" @default.
• W2094103522 title "Stratification of de novo Adult Acute Myelogenous Leukemia with Adverse-Risk Karyotype: Can We Overcome the Worse Prognosis of Adverse-Risk Group Acute Myelogenous Leukemia with Hematopoietic Stem Cell Transplantation?" @default.
• W2094103522 cites W101202223 @default.
• W2094103522 cites W1492609361 @default.
• W2094103522 cites W1534965621 @default.
• W2094103522 cites W1868738875 @default.
• W2094103522 cites W1972047494 @default.
• W2094103522 cites W1975970246 @default.
• W2094103522 cites W1979616872 @default.
• W2094103522 cites W1984655249 @default.
• W2094103522 cites W1990256332 @default.
• W2094103522 cites W2000792463 @default.
• W2094103522 cites W2025292843 @default.
• W2094103522 cites W2028142301 @default.
• W2094103522 cites W2032699876 @default.
• W2094103522 cites W2035746883 @default.
• W2094103522 cites W2038815761 @default.
• W2094103522 cites W2045490767 @default.
• W2094103522 cites W2059210394 @default.
• W2094103522 cites W2073140442 @default.
• W2094103522 cites W2076668534 @default.
• W2094103522 cites W2092727119 @default.
• W2094103522 cites W2100883771 @default.
• W2094103522 cites W2116858301 @default.
• W2094103522 cites W2117446917 @default.
• W2094103522 cites W2141034604 @default.
• W2094103522 cites W2141368628 @default.
• W2094103522 cites W2144244435 @default.
• W2094103522 cites W2144395887 @default.
• W2094103522 cites W2148047805 @default.
• W2094103522 cites W2170510628 @default.
• W2094103522 cites W2587631365 @default.
• W2094103522 doi "https://doi.org/10.1016/j.bbmt.2013.10.015" @default.
• W2094103522 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24149098" @default.
• W2094103522 hasPublicationYear "2014" @default.
• W2094103522 type Work @default.
• W2094103522 sameAs 2094103522 @default.
• W2094103522 citedByCount "7" @default.
• W2094103522 countsByYear W20941035222015 @default.
• W2094103522 countsByYear W20941035222016 @default.
• W2094103522 countsByYear W20941035222018 @default.
• W2094103522 countsByYear W20941035222019 @default.
• W2094103522 crossrefType "journal-article" @default.
• W2094103522 hasAuthorship W2094103522A5019604231 @default.
• W2094103522 hasAuthorship W2094103522A5026190297 @default.
• W2094103522 hasAuthorship W2094103522A5033356298 @default.
• W2094103522 hasAuthorship W2094103522A5034751203 @default.
• W2094103522 hasAuthorship W2094103522A5036020306 @default.
• W2094103522 hasAuthorship W2094103522A5044372572 @default.
• W2094103522 hasAuthorship W2094103522A5050292329 @default.
• W2094103522 hasAuthorship W2094103522A5055206475 @default.
• W2094103522 hasAuthorship W2094103522A5059291757 @default.
• W2094103522 hasAuthorship W2094103522A5061707434 @default.
• W2094103522 hasAuthorship W2094103522A5074128691 @default.
• W2094103522 hasAuthorship W2094103522A5084426605 @default.
• W2094103522 hasAuthorship W2094103522A5086415059 @default.
• W2094103522 hasAuthorship W2094103522A5086500437 @default.
• W2094103522 hasBestOaLocation W20941035221 @default.
• W2094103522 hasConcept C104317684 @default.
• W2094103522 hasConcept C126322002 @default.
• W2094103522 hasConcept C143998085 @default.
• W2094103522 hasConcept C197934379 @default.
• W2094103522 hasConcept C203014093 @default.
• W2094103522 hasConcept C2777408962 @default.
• W2094103522 hasConcept C2778461978 @default.
• W2094103522 hasConcept C2911091166 @default.
• W2094103522 hasConcept C30481170 @default.
• W2094103522 hasConcept C53226629 @default.
• W2094103522 hasConcept C54355233 @default.
• W2094103522 hasConcept C71924100 @default.
• W2094103522 hasConcept C86803240 @default.
• W2094103522 hasConcept C90924648 @default.
• W2094103522 hasConceptScore W2094103522C104317684 @default.
• W2094103522 hasConceptScore W2094103522C126322002 @default.
• W2094103522 hasConceptScore W2094103522C143998085 @default.
• W2094103522 hasConceptScore W2094103522C197934379 @default.
• W2094103522 hasConceptScore W2094103522C203014093 @default.
• W2094103522 hasConceptScore W2094103522C2777408962 @default.
• W2094103522 hasConceptScore W2094103522C2778461978 @default.
• W2094103522 hasConceptScore W2094103522C2911091166 @default.
• W2094103522 hasConceptScore W2094103522C30481170 @default.

• next